Erythromycin/benzoyl peroxide
Combination of | |
---|---|
Erythromycin | Antibiotic |
Benzoyl peroxide | Antiseptic |
Clinical data | |
Trade names | Benzamycin |
AHFS/Drugs.com | Multum Consumer Information |
MedlinePlus | a603024 |
License data | |
Routes of administration | Topical |
Legal status | |
Legal status |
|
Erythromycin/benzoyl peroxide, sold under the brand name Benzamycin, is a topical gel containing of 5% benzoyl peroxide and 3% erythromycin primarily used to treat acne.[1] Erythromycin/benzoyl peroxide is a prescription medication.[2]
Side effects include dry skin, stinging, redness, and itchy rash (urticaria),[2] with recommended usage is 2 times per day, once in the morning and once in the evening, or as prescribed by a doctor. The affected area should be washed with soap and warm water, rinsed, and gently dried before applying the gel.[3] Using an oil-free face moisturizer in conjunction with erythromycin/benzoyl peroxide is recommended.
Erythromycin/benzoyl peroxide was approved by the US Food and Drug Administration in 1984.[2] On March 30, 2004, a generic form of Benzamycin was released by pharmaceutical company Atrix Laboratories.[4]
![]() | This section needs to be updated.(September 2022) |
References
- ^ "Benzamycin Uses, Side Effects & Warnings". Drugs.com. Retrieved 2022-09-21.
- ^ a b c "Benzamycin® Topical Gel (erythromycin-benzoyl peroxide gel)". dailymed.nlm.nih.gov. Retrieved 2022-09-21.
- ^ "Benzamycin (Erythromycin): Uses, Dosage, Side Effects, Interactions, Warning". RxList. Retrieved 2022-09-21.
- ^ "CIBC World Upgrades Atrix Laboratories". Bloomberg.com. Retrieved 2023-08-24.
External links
- "Atrix Laboratories, Inc. (ATRX) Receives FDA Approval For Erythromycin/Benzoyl Peroxide", Biospace.com, 10/19/2005